SLC2A4, solute carrier family 2 member 4, 6517

N. diseases: 158; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 AlteredExpression disease BEFREE WL women displayed decreased pro-inflammatory (NLRP3) but increased insulin-response gene (FASN and GLUT4) expression over time. 31164724 2020
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 AlteredExpression disease BEFREE Although gonadotrophins and insulin increased GLUT-4 expression, neither modified 6-NBDG incorporation. 30955508 2019
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 Biomarker disease BEFREE We propose that maternal insulin stimulates placental glucose transport by promoting GLUT4 trafficking to the BM, which may enhance glucose transfer to the fetus in response to postprandial hyperinsulinemia in women with normal BMI. 31112275 2019
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 AlteredExpression disease BEFREE We provided some mechanisms of action for osteocalcin in the amelioration of insulin resistance in obesity: in WAT, osteocalcin improves insulin resistance by decreasing inflammation, and increasing insulin signaling and the expression of Slc2a4/GLUT4; and, in bone, osteocalcin increases the secretion of uncarboxylated osteocalcin by improving insulin resistance. 29183784 2018
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 AlteredExpression disease BEFREE E<sub>2</sub> induced (1) translocation of ESR1, but not of ESR2, from nucleus to plasma membrane and AKT phosphorylation, effects mimicked by PPT and blocked by MPP and PP2; (2) increased <i>Slc2a4</i>/GLUT4 expression and (3) increased insulin-stimulated GLUT4 translocation and glucose uptake. 28729437 2017
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 Biomarker disease BEFREE TRG (50 mg/kg; p.o) lowered serum glucose, fructosamine, insulin, and HOMA-IR index and increased insulin sensitivity in soleus muscle via augmenting insulin receptor autophosphorylation (IR-PH), pT308-Akt, and glucose transporter 4 (GLUT4). 28271502 2017
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 AlteredExpression disease BEFREE In diabetes, energy excess and prolonged hyperinsulinemia suppress muscle and adipose response to insulin, in part through reduced GLUT4 membrane levels. 25215442 2015
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 Biomarker disease BEFREE Our data suggest that hyperinsulinemia may inhibit GLUT4 by chronically maintaining GLUT4 in the Rab5 activity-dependent endosomal pathway and impairing formation of the TfR-negative and TfR-positive insulin-responsive GLUT4 pools. 24932807 2014
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 AlteredExpression disease BEFREE We aimed to estimate the response of glucose transporter 4 (GLUT4) and hexokinase-II (HKII) gene expression to hyperinsulinemia before and after surgical treatment with a BPD or dietary-induced weight loss. 23341487 2013
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 AlteredExpression disease BEFREE GE treated groups improved the glucose tolerance, attenuated hyperglycemia and hyperinsulinemia in the mice by up-regulating the adiponectin and GLUT-4 gene expressions. 23259700 2012
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 AlteredExpression disease BEFREE Hyperinsulinemia, associated with partial lipodystrophy, elevated RBP4, low adiponectin levels, and decreased expression of GLUT3 and GLUT4 were detected. 21883748 2012
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 GeneticVariation disease BEFREE Here we show in a model of chronic hyperinsulinemia that adipocytes develop selective insulin resistance in which translocation of the GLUT4 glucose transporter to the cell surface is blunted yet nuclear exclusion of the FoxO1 transcription factor is preserved, rendering uncoupled insulin-controlled carbohydrate and lipid metabolisms. 21646544 2011
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 AlteredExpression disease BEFREE Results show that whole body and tissue-specific indices of glucose utilization were: (1) augmented by GLUT4 overexpression, but not HKII overexpression, in the basal state; (2) enhanced by HKII overexpression in the presence of physiological hyperinsulinaemia; and (3) largely unaffected by GLUT4 overexpression during insulin clamps whether alone or combined with HKII overexpression. 15576451 2005
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 Biomarker disease BEFREE In conclusion, our data demonstrate that GLUT4 is present in the endometrium of normal and PCOS subjects and that hyperinsulinism and obesity seem to have a negative effect on endometrial GLUT4 expression in PCOS. 15292352 2004
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 Biomarker disease BEFREE Previous work suggests that normal GLUT4 content is sufficient for increases in muscle glucose uptake (MGU) during hyperinsulinemia, because glucose phosphorylation is the more formidable barrier to insulin-stimulated MGU. 15284204 2004
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 AlteredExpression disease BEFREE During the insulin clamp performed after 24 and 72 h of sustained physiological hyperinsulinemia, the ability of insulin to increase muscle GS fractional velocity, total body glucose disposal, and nonoxidative glucose disposal was impaired (all P < 0.01), whereas the effect of insulin on muscle HKII mRNA, HKII activity, GLUT-4 protein content, and whole body rates of glucose oxidation and glycolysis remained unchanged. 11287353 2001
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 GeneticVariation disease BEFREE This point also became apparent by the development of only mild hyperinsulinaemia in mice with a targeted mutation in the Glut-4 gene. 10395191 1999
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 AlteredExpression disease BEFREE We report that expression of GLUT-4 is reduced in NIDDM and in obesity associated with hyperinsulinemia and insulin resistance. 7868815 1994
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.100 AlteredExpression disease BEFREE Insulin increased GLUT-4 mRNA levels in all control subjects (from 68 +/- 5 to 92 +/- 6 pg/micrograms RNA; p < 0.0001), but not in the diabetic patients (from 99 +/- 8 to 90 +/- 8 pg/micrograms RNA, NS), or their relatives (from 94 +/- 9 to 101 +/- 11 pg/micrograms RNA, NS). 8063042 1994